Can diet boost immunotherapy? study tests High-Fiber and fasting in melanoma
NCT ID NCT07680452
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at whether adding a high-fiber diet and short-term fasting can help melanoma patients undergoing immunotherapy. Forty participants will follow a high-fiber diet, with half also doing 72-hour fasts during each treatment cycle, while 20 others serve as a control group. The main goal is to see if this approach is feasible, with exploratory checks on quality of life, side effects, and immune system changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-fiber diet and short-term fasting
What this could lead to
If successful, this could pave the way for larger studies on dietary support to improve immunotherapy effectiveness and reduce side effects in melanoma.
What could go wrong
This is an early feasibility study with only 60 participants, so results may not be conclusive. Dietary interventions can be hard to follow, and the study may not show clear benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- TIL Therapy for Resistant Melanoma Trial NCT07651618
- Melanoma SLNB Decision Aid Trial | NCT07653087
- Digital phenotyping of distress in skin cancer p NCT07670403
- Bright Light Therapy for Immunotherapy Patients NCT07661966
- AI Nutrition for Taste Changes in Cancer: NCT07649681
- ECP vs Best Therapy for ICI Colitis/Hepatitis NCT07619898
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany